ePoster

GABAERGIC MODULATION OF CORTICAL EXCITABILITY ASSESSED VIA TRANSCRANIAL MAGNETIC STIMULATION IN NON-HUMAN PRIMATES

Anna Padányiand 5 co-authors

University of Pécs

FENS Forum 2026 (2026)
Barcelona, Spain
Board PS03-08AM-146

Presentation

Date TBA

Board: PS03-08AM-146

Poster preview

GABAERGIC MODULATION OF CORTICAL EXCITABILITY ASSESSED VIA TRANSCRANIAL MAGNETIC STIMULATION IN NON-HUMAN PRIMATES poster preview

Event Information

Poster Board

PS03-08AM-146

Abstract

Cortical excitability (CE) is defined as the general responsiveness of the cortex to incoming stimuli. Utilising non-invasive brain stimulation in a translational research framework, we quantified multiple comparable CE indices in awake rhesus macaque monkeys via motor threshold (MT) and recruitment curve (RC) protocols. Additionally, we tested the pharmacological modulation of CE by inhibitory GABA-receptor-specific agents. Using neuronavigation-guided single-pulse TMS on the primary motor cortex with motor-evoked potential (MEP) readout measured from the flexor muscle of the thumb, we implemented both the traditional relative-frequency motor threshold (tradMT) and the Stochastic Approximator of Motor Threshold (SAMT) methods. Then, recruitment curves (RC) were acquired at nine stimulation intensities (50-150% of MT) with 8-10 single-pulses per intensity level in a randomised order. Both MT and RC-derived MT values were stable, reliable and replicable. Systemic administration of GABAA receptor modulator diazepam (0.1, 0.3, 1 mg/kg, n=4) or GABAB receptor agonist baclofen (1 or 3 mg/kg, n=5) revealed distinct inhibitory profiles. Diazepam dose-dependently shifted RC to the right at 10 min post-administration (p<0.001). A similar but weaker inhibitory effect was present in only the large dose of RS-baclofen and at much longer waiting times (2 or 4 hrs, p<0.001). Here we demonstrated that human-relevant CE metrics can be successfully implemented in awake monkeys and that RCs highlight differences in the mechanism of GABAA and GABABreceptor modulation. The system-level evaluation of pharmacological interventions supports the development of therapies targeting CE alterations in psychiatric and neurocognitive diseases.

Recommended posters

Cookies

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.